Pharmas

New CBD Regulatory Framework Published by France’s Ministry of Health Opens New Commercial Opportunities for RAMM Pharma’s European Operations

Posted on by Linda Rider
New CBD Regulatory Framework Published by France’s Ministry of Health Opens New Commercial Opportunities for RAMM Pharma’s European Operations

TORONTO, Jan. 05, 2022 (Globe NEWSWIRE) — RAMM Pharma Corp., which includes its wholly owned subsidiaries, the “Enterprise” or “RAMM”) (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical solutions, applauds France’s new regulatory framework for the sale of cannabidiol (“CBD”). Pursuant to the recent announcement, France will enable the utilization of the total hemp plant, […]

Read More